Prospective study of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting using novel metal stent

Prospective study of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting using novel metal stent - Prospective study of endoscopic ultrasound-guided hepaticogastrostomy with antegrade stenting using novel stent

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035724

Enrollment

Registered

2019-01-31

Start date

2019-01-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Jaundice

Interventions

EUS-HGS with EUS-AS using novet metal stent(Zilver type 2)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: nonresectable advanced malignant tumor case Cases requiring biliary duct drainage due to malignant bile duct obstruction Difficult cases of biliary drainage via Vater papilla approach Cases in which survival is expected for more than 3 months

Exclusion criteria

Exclusion criteria: Difficult cases of endoscopic approach Perfomance status 4 case Cases with serious complications in other organs Informed consent case not available

Design outcomes

Primary

Measure	Time frame
EUS-HGAS procedure success rate	—

Secondary

Measure	Time frame
Type, frequency of adverse events. 3 months after EUS - HGAS stent patency. Clinical efficacy rate.	—

Countries

Japan

Contacts

Public ContactSaori Ueno

Osaka Medical College Hospital Gastrointestinal Division

onchannopasocon@yahoo.co.jp+81726831221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026